Essential medicines are more available than other medicines around the globe.
BACKGROUND: The World Health Organization (WHO) promotes the development of national Essential Medicines Lists (EMLs) in order to improve the availability and use of medicines considered essential within health care systems. However, despite over 3 decades of international efforts, studies show an i...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3922716?pdf=render |
| _version_ | 1819129014489448448 |
|---|---|
| author | Yaser T Bazargani Margaret Ewen Anthonius de Boer Hubert G M Leufkens Aukje K Mantel-Teeuwisse |
| author_facet | Yaser T Bazargani Margaret Ewen Anthonius de Boer Hubert G M Leufkens Aukje K Mantel-Teeuwisse |
| author_sort | Yaser T Bazargani |
| collection | DOAJ |
| description | BACKGROUND: The World Health Organization (WHO) promotes the development of national Essential Medicines Lists (EMLs) in order to improve the availability and use of medicines considered essential within health care systems. However, despite over 3 decades of international efforts, studies show an inconsistent pattern in the availability of essential medicines. We evaluated and compared the availability of essential medicines, and medicines not included in national EMLs, at global and regional levels. METHODS: Medicine availability in the public and private sector were calculated based on data obtained from national and provincial facility-based surveys undertaken in 23 countries using the WHO/HAI methodology. The medicines were grouped according to their inclusion ('essential') or exclusion (termed 'non-essential') in each country's EML current at the time of the survey. Availability was calculated for originator brands, generics and any product type (originator brands or generics) and compared between the two groups. Results were aggregated by WHO regions, World Bank country income groups, a wealth inequality measure, and therapeutic groups. FINDINGS: Across all sectors and any product type, the median availability of essential medicines was suboptimal at 61·5% (IQR 20·6%-86·7%) but significantly higher than non-essential medicines at 27·3% (IQR 3·6%-70·0%). The median availability of essential medicines was 40·0% in the public sector and 78·1% in the private sector; compared to 6·6% and 57·1% for non-essential medicines respectively. A reverse trend between national income level categories and the availability of essential medicines was identified in the public sector. INTERPRETATION: EMLs have influenced the provision of medicines and have resulted in higher availability of essential medicines compared to non-essential medicines particularly in the public sector and in low and lower middle income countries. However, the availability of essential medicines, especially in the public sector does not ensure equitable access. |
| first_indexed | 2024-12-22T08:36:59Z |
| format | Article |
| id | doaj.art-c257b388323d4eb2a228ba228dd03af0 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T08:36:59Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-c257b388323d4eb2a228ba228dd03af02022-12-21T18:32:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8757610.1371/journal.pone.0087576Essential medicines are more available than other medicines around the globe.Yaser T BazarganiMargaret EwenAnthonius de BoerHubert G M LeufkensAukje K Mantel-TeeuwisseBACKGROUND: The World Health Organization (WHO) promotes the development of national Essential Medicines Lists (EMLs) in order to improve the availability and use of medicines considered essential within health care systems. However, despite over 3 decades of international efforts, studies show an inconsistent pattern in the availability of essential medicines. We evaluated and compared the availability of essential medicines, and medicines not included in national EMLs, at global and regional levels. METHODS: Medicine availability in the public and private sector were calculated based on data obtained from national and provincial facility-based surveys undertaken in 23 countries using the WHO/HAI methodology. The medicines were grouped according to their inclusion ('essential') or exclusion (termed 'non-essential') in each country's EML current at the time of the survey. Availability was calculated for originator brands, generics and any product type (originator brands or generics) and compared between the two groups. Results were aggregated by WHO regions, World Bank country income groups, a wealth inequality measure, and therapeutic groups. FINDINGS: Across all sectors and any product type, the median availability of essential medicines was suboptimal at 61·5% (IQR 20·6%-86·7%) but significantly higher than non-essential medicines at 27·3% (IQR 3·6%-70·0%). The median availability of essential medicines was 40·0% in the public sector and 78·1% in the private sector; compared to 6·6% and 57·1% for non-essential medicines respectively. A reverse trend between national income level categories and the availability of essential medicines was identified in the public sector. INTERPRETATION: EMLs have influenced the provision of medicines and have resulted in higher availability of essential medicines compared to non-essential medicines particularly in the public sector and in low and lower middle income countries. However, the availability of essential medicines, especially in the public sector does not ensure equitable access.http://europepmc.org/articles/PMC3922716?pdf=render |
| spellingShingle | Yaser T Bazargani Margaret Ewen Anthonius de Boer Hubert G M Leufkens Aukje K Mantel-Teeuwisse Essential medicines are more available than other medicines around the globe. PLoS ONE |
| title | Essential medicines are more available than other medicines around the globe. |
| title_full | Essential medicines are more available than other medicines around the globe. |
| title_fullStr | Essential medicines are more available than other medicines around the globe. |
| title_full_unstemmed | Essential medicines are more available than other medicines around the globe. |
| title_short | Essential medicines are more available than other medicines around the globe. |
| title_sort | essential medicines are more available than other medicines around the globe |
| url | http://europepmc.org/articles/PMC3922716?pdf=render |
| work_keys_str_mv | AT yasertbazargani essentialmedicinesaremoreavailablethanothermedicinesaroundtheglobe AT margaretewen essentialmedicinesaremoreavailablethanothermedicinesaroundtheglobe AT anthoniusdeboer essentialmedicinesaremoreavailablethanothermedicinesaroundtheglobe AT hubertgmleufkens essentialmedicinesaremoreavailablethanothermedicinesaroundtheglobe AT aukjekmantelteeuwisse essentialmedicinesaremoreavailablethanothermedicinesaroundtheglobe |